• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Infusion-related and hypersensitivity reactions of monoclonal antibodies used to treat colorectal cancer--identification, prevention, and management.

作者信息

Kang Soonmo Peter, Saif Muhammad Wasif

机构信息

Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut 06510, USA.

出版信息

J Support Oncol. 2007 Oct;5(9):451-7.

PMID:18019853
Abstract
摘要

相似文献

1
Infusion-related and hypersensitivity reactions of monoclonal antibodies used to treat colorectal cancer--identification, prevention, and management.用于治疗结直肠癌的单克隆抗体的输液相关反应和超敏反应——识别、预防及管理
J Support Oncol. 2007 Oct;5(9):451-7.
2
Managing premedications and the risk for reactions to infusional monoclonal antibody therapy.管理预处理药物及输注性单克隆抗体治疗的反应风险。
Oncologist. 2008 Jun;13(6):725-32. doi: 10.1634/theoncologist.2008-0012.
3
Management and preparedness for infusion and hypersensitivity reactions.输液及过敏反应的管理与准备
Oncologist. 2007 May;12(5):601-9. doi: 10.1634/theoncologist.12-5-601.
4
[Incidence of infusion reactions induced by cetuximab chemotherapy].[西妥昔单抗化疗引起的输注反应发生率]
Gan To Kagaku Ryoho. 2011 Jun;38(6):963-6.
5
[Infusion reactions].[输液反应]
Gan To Kagaku Ryoho. 2008 Oct;35(10):1671-4.
6
Managing cetuximab hypersensitivity-infusion reactions: incidence, risk factors, prevention, and retreatment.管理西妥昔单抗超敏反应性输注反应：发生率、危险因素、预防及再次治疗
J Support Oncol. 2010 Mar-Apr;8(2):72-7.
7
Re-treatment with cetuximab in patients with severe hypersensitivity reactions to cetuximab. Two case reports.
Acta Oncol. 2006;45(8):1137-8. doi: 10.1080/02841860600871764.
8
Hypersensitivity reactions to oxaliplatin: what nurses need to know.对奥沙利铂的超敏反应：护士需要了解的内容。
Clin J Oncol Nurs. 2005 Jun;9(3):325-30. doi: 10.1188/05.CJON.325-330.
9
The impact of infusion reactions associated with monoclonal antibodies in metastatic colorectal cancer: a European perspective.转移性结直肠癌中与单克隆抗体相关的输注反应的影响：欧洲视角
J Oncol Pharm Pract. 2013 Mar;19(1):38-47. doi: 10.1177/1078155212451197. Epub 2012 Jun 26.
10
Management of severe infusion reactions after cetuximab.
Acta Oncol. 2008;47(8):1609-11. doi: 10.1080/02841860802123204.

引用本文的文献

1
Risk factors and clinical consequences of rituximab infusion-related reactions.利妥昔单抗输注相关反应的危险因素及临床后果。
Medicine (Baltimore). 2025 Jun 27;104(26):e42972. doi: 10.1097/MD.0000000000042972.
2
First-in-Human Study of BAT4406F, an ADCC-Enhanced Fully Humanized Anti-CD20 Monoclonal Antibody in Patients With Neuromyelitis Optica Spectrum Disorders.BAT4406F 是一种 ADCC 增强的全人源化抗 CD20 单克隆抗体，在视神经脊髓炎谱系障碍患者中的首次人体研究。
CNS Neurosci Ther. 2024 Nov;30(11):e70126. doi: 10.1111/cns.70126.
3
A review of cutting-edge therapies for hepatocellular carcinoma (HCC): Perspectives from patents.
肝细胞癌（HCC）前沿治疗方法综述：专利视角。
Int J Med Sci. 2021 Jun 18;18(14):3066-3081. doi: 10.7150/ijms.59930. eCollection 2021.
4
The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies.噬菌体治疗的安全性和毒性：动物和临床研究综述。
Viruses. 2021 Jun 29;13(7):1268. doi: 10.3390/v13071268.
5
Monoclonal Antibodies as Neurological Therapeutics.单克隆抗体作为神经学治疗药物
Pharmaceuticals (Basel). 2021 Jan 26;14(2):92. doi: 10.3390/ph14020092.
6
Successful rechallenge with cetuximab after an infusion related reaction to panitumumab in a patient with locally advanced rectal cancer.一名局部晚期直肠癌患者在对帕尼单抗发生输液相关反应后成功再次使用西妥昔单抗。
Int Cancer Conf J. 2020 Oct 30;10(1):87-90. doi: 10.1007/s13691-020-00455-x. eCollection 2021 Jan.
7
Hypersensitivity Reactions to Monoclonal Antibodies in Children.儿童对单克隆抗体的过敏反应。
Medicina (Kaunas). 2020 May 12;56(5):232. doi: 10.3390/medicina56050232.
8
Immunogenicity of TNF-Inhibitors.肿瘤坏死因子抑制剂的免疫原性。
Front Immunol. 2020 Feb 26;11:312. doi: 10.3389/fimmu.2020.00312. eCollection 2020.
9
The importance of early identification of infusion-related reactions to monoclonal antibodies.早期识别单克隆抗体输注相关反应的重要性。
Ther Clin Risk Manag. 2019 Aug 1;15:965-977. doi: 10.2147/TCRM.S204909. eCollection 2019.
10
PEGylated liposomes: immunological responses.聚乙二醇化脂质体：免疫反应。
Sci Technol Adv Mater. 2019 Jun 26;20(1):710-724. doi: 10.1080/14686996.2019.1627174. eCollection 2019.